Literature DB >> 18317742

Induction of muscle cramps by nociceptive stimulation of latent myofascial trigger points.

Hong-You Ge1, Yang Zhang, Shellie Boudreau, Shou-Wei Yue, Lars Arendt-Nielsen.   

Abstract

The aim of this present study is to test the hypothesis that nociceptive stimulation of latent myofascial trigger points (MTrPs) increases the occurrence of local muscle cramps. Nociceptive muscle stimulation was obtained by a bolus injection of glutamate (0.1 ml, 0.5 M) into a latent MTrP and a control point (a non-MTrP) located in the right or left gastrocnemius medialis muscles in 14 healthy subjects. A bolus of isotonic saline (0.9%, 0.1 ml) injection served as a control. The injections were guided by intramuscular electromyography (EMG) showing resting spontaneous electrical activity at a latent MTrP and no such activity at a non-MTrP. Intramuscular and surface EMG activities in the gastrocnemius medialis muscle were recorded pre-, during-, and post-injection for a period of 8 min to monitor the occurrence of muscle cramps, which are characterized by a brief episodic burst of high levels of EMG activity. The results showed that glutamate and isotonic saline injections into the latent MTrPs induced higher peak pain intensity than into the non-MTrPs (both P < 0.05). Glutamate injection induced higher peak pain intensity than isotonic saline injection into either latent MTrPs or non-MTrPs (both P < 0.05). Muscle camps were observed in 92.86% of the subjects following glutamate injection into the latent MTrPs, but not into the non-MTrPs (P < 0.001). No muscle cramps were recorded following isotonic saline injection into either the latent MTrPs or the non-MTrPs. These results suggest that latent MTrPs could be involved in the genesis of muscle cramps. Focal increase in nociceptive sensitivity at MTrPs constitutes one of the mechanisms underlying muscle cramps.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18317742     DOI: 10.1007/s00221-008-1331-y

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  29 in total

1.  Possible mechanisms of muscle cramp from temporal and spatial surface EMG characteristics.

Authors:  K Roeleveld; B G van Engelen; D F Stegeman
Journal:  J Appl Physiol (1985)       Date:  2000-05

Review 2.  An expansion of Simons' integrated hypothesis of trigger point formation.

Authors:  Robert D Gerwin; Jan Dommerholt; Jay P Shah
Journal:  Curr Pain Headache Rep       Date:  2004-12

3.  The incidence of muscle cramp.

Authors:  P H Jansen; E M Joosten; J Van Dijck; A L Verbeek; F W Durian
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-12       Impact factor: 10.154

4.  Glutamate-induced sensitization of rat masseter muscle fibers.

Authors:  B E Cairns; G Gambarota; P Svensson; L Arendt-Nielsen; C B Berde
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

5.  Sympathetic facilitation of hyperalgesia evoked from myofascial tender and trigger points in patients with unilateral shoulder pain.

Authors:  Hong-You Ge; César Fernández-de-las-Peñas; Lars Arendt-Nielsen
Journal:  Clin Neurophysiol       Date:  2006-06-05       Impact factor: 3.708

Review 6.  Cramps.

Authors:  R B Layzer; L P Rowland
Journal:  N Engl J Med       Date:  1971-07-01       Impact factor: 91.245

7.  Reliability of the pressure algometer as a measure of myofascial trigger point sensitivity.

Authors:  John L Reeves; Bernadette Jaeger; Steven B Graff-Radford
Journal:  Pain       Date:  1986-03       Impact factor: 6.961

8.  The influence of muscular lengthening on cramps.

Authors:  L Bertolasi; D De Grandis; L G Bongiovanni; G P Zanette; M Gasperini
Journal:  Ann Neurol       Date:  1993-02       Impact factor: 10.422

9.  Actions on gamma-motoneurones elicited by electrical stimulation of group III muscle afferent fibres in the hind limb of the cat.

Authors:  B Appelberg; M Hulliger; H Johansson; P Sojka
Journal:  J Physiol       Date:  1983-02       Impact factor: 5.182

10.  Presynaptic excitability changes of group Ia fibres to muscle nociceptive stimulation in humans.

Authors:  A Rossi; B Decchi; F Ginanneschi
Journal:  Brain Res       Date:  1999-02-06       Impact factor: 3.252

View more
  15 in total

1.  A afferent fibers are involved in the pathology of central changes in the spinal dorsal horn associated with myofascial trigger spots in rats.

Authors:  Fei Meng; Hong-You Ge; Yong-Hui Wang; Shou-Wei Yue
Journal:  Exp Brain Res       Date:  2015-07-26       Impact factor: 1.972

Review 2.  Myofascial trigger points: peripheral or central phenomenon?

Authors:  César Fernández-de-las-Peñas; Jan Dommerholt
Journal:  Curr Rheumatol Rep       Date:  2014-01       Impact factor: 4.592

Review 3.  Clinical implication of latent myofascial trigger point.

Authors:  Derya Celik; Ebru Kaya Mutlu
Journal:  Curr Pain Headache Rep       Date:  2013-08

Review 4.  The impact of latent trigger points on regional muscle function.

Authors:  Karen R Lucas
Journal:  Curr Pain Headache Rep       Date:  2008-10

5.  Dry needling - peripheral and central considerations.

Authors:  Jan Dommerholt
Journal:  J Man Manip Ther       Date:  2011-11

Review 6.  Latent myofascial trigger points.

Authors:  Hong-You Ge; Lars Arendt-Nielsen
Journal:  Curr Pain Headache Rep       Date:  2011-10

Review 7.  Prevalence of myofascial trigger points in fibromyalgia: the overlap of two common problems.

Authors:  Hong-You Ge
Journal:  Curr Pain Headache Rep       Date:  2010-10

8.  Myofascial trigger points: spontaneous electrical activity and its consequences for pain induction and propagation.

Authors:  Hong-You Ge; César Fernández-de-Las-Peñas; Shou-Wei Yue
Journal:  Chin Med       Date:  2011-03-25       Impact factor: 5.455

Review 9.  Neurogenic muscle cramps.

Authors:  Hans D Katzberg
Journal:  J Neurol       Date:  2015-02-12       Impact factor: 4.849

10.  Effect of latent myofascial trigger points on strength measurements of the upper trapezius: a case-controlled trial.

Authors:  Magesh Anand Doraisamy
Journal:  Physiother Can       Date:  2011-10-20       Impact factor: 1.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.